Earlier this month, the Antitrust Division of the DOJ, the Department of Health and Human Services, and the Federal Trade Commission announced a joint cross-government inquiry into the control over health care by private equity firms and other corporate owners, and, in conjunction with that announcement, released a Request for Information seeking public comment from stakeholders, including patients, consumer advocates, doctors, nurses, health care administrators, employers, private insurers, PBMs, GPOs, nursing homes, hospices, home health agencies, hospitals, and […]

On March 5, 2024, the Federal Trade Commission (“FTC”), the Department of Justice (“DOJ”) Antitrust Division, and Department of Health and Human Services (“HHS”) announced that they are launching a “cross-government public inquiry into private equity and other corporations’ increasing control over health care.” This effort is another step by regulators in their increased scrutiny of private equity. The inquiry seeks to understand how private equity transactions in the healthcare field affect consolidation, as well as […]